Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
- 20 May 2015
- journal article
- research article
- Published by Springer Nature in Biogerontology
- Vol. 16 (5) , 671-683
Abstract
Human natural killer (NK) cells are innate lymphoid cells with capacity to kill tumor cells and virus-infected cells. According to the expression of CD56 and CD16 several NK cell subsets have been identified, a major CD56dimCD16+ subpopulation characterized by higher cytotoxic capacity, two CD56bright subsets (CD16−and CD16+) that represent different maturation stages and the fourth CD56−CD16+ subset that correspond to activated dysfunctional NK cells. Previous studies have shown quantitative changes in the frequency, phenotype and distribution of NK cell subsets depending on CMV-serostatus and age. We have analyzed the expression of NKp30, NKp46 and DNAM-1 NK activating receptors on resting and IL-2 activated NK cells from CMV-seronegative and seropositive healthy young donors and from CMV-seropositive elderly individuals. Our results showed that CMV-serostatus of healthy young donors is associated with phenotypic differences on both CD56bright and CD56dim NK cells with an increase of NKp46 and a decrease of NKp30 expression respectively. A reduced expression of DNAM-1 related to ageing and a lower NKp30 expression associated with CMV-seropositivity were observed. The expression of NKp46 and NKp30 was lower in CD57+ NK cells while the expression of DNAM-1 was increased. In vitro NK cell activation by IL-2 increased the expression of NKp46 and NKp30. In summary, both age and CMV-serostatus influence the expression of these cytotoxicity activating receptors that will have functional consequences. In elderly donors is difficult to isolate age from the effect of chronic CMV infection since in our study all elderly donors were CMV-seropositive. The possibility of modulating the expression of these activating receptors by cytokines such as IL-2 may open new opportunities for improving age-associated deterioration of NK cell function.Keywords
Funding Information
- Spanish Ministry of Health (PS09/00723, PI13/02691)
- Junta de Andalucia co-financed by European Regional Development Fund (FEDER)
- Ministry of Science and Innovation of Spain (SAF2009-09711, SAF2013-46161-R)
- INPATT research group from Junta de Extremadura co-financed by European Regional Development Fund (FEDER) (GRU10104)
This publication has 70 references indexed in Scilit:
- CD56negCD16+NK cells are activated mature NK cells with impaired effector function during HIV-1 infectionRetrovirology, 2013
- NK Cells in Healthy Aging and Age-Associated DiseasesJournal of Biomedicine and Biotechnology, 2012
- Expansion of a unique CD57+NKG2Chinatural killer cell subset during acute human cytomegalovirus infectionProceedings of the National Academy of Sciences, 2011
- Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirusJournal of Experimental Medicine, 2010
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subsetBlood, 2010
- Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112Journal of General Virology, 2010
- CD56bright natural killer (NK) cells: an important NK cell subsetImmunology, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionImmunology, 2007
- Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirusNature Immunology, 2005